Rociverine: Difference between revisions

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 12:19, 12 August 2011 editCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation\|Chem/Drugbox← Previous edit		Revision as of 08:23, 3 September 2011 edit undoBogBot (talk \| contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot Next edit →
Line 1:		Line 1:
	{{~~drugbox~~		{{Drugbox
⚫	\| UNII_Ref = {{fdacite\|correct\|FDA}}
⚫	\| UNII = VI08KS44V0
	\| verifiedrevid = 443791079		\| verifiedrevid = 443791079
	\| IUPAC_name = 2-(diethylamino)-1-methylethyl (1''S'')-1-hydroxy-1,1'-bi(cyclohexyl)-2-carboxylate		\| IUPAC_name = 2-(diethylamino)-1-methylethyl (1''S'')-1-hydroxy-1,1'-bi(cyclohexyl)-2-carboxylate
		⚫	\| image = Rociverine.png
⚫	\|synonyms = <small>(1''S'')-1-(diethylamino)propan-2-yl 1-hydroxybi(cyclohexane)-2-carboxylate</small>

⚫	\| image = Rociverine.png
			<!--Clinical data-->
⚫	\| CAS_number = 53716-44-2
			\| tradename =
⚫	\| ATC_prefix = A03
			\| Drugs.com = {{drugs.com\|international\|rociverine}}
⚫	\| ATC_suffix = AA06
	\| ~~PubChem~~ = ~~68705~~		\| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
		⚫	\| pregnancy_US = <!-- A / B / C / D / X -->
		⚫	\| pregnancy_category =
		⚫	\| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
		⚫	\| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
		⚫	\| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
		⚫	\| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
		⚫	\| legal_status =
		⚫	\| routes_of_administration =

			<!--Pharmacokinetic data-->
		⚫	\| bioavailability =
		⚫	\| protein_bound =
			\| metabolism =
		⚫	\| elimination_half-life =
		⚫	\| excretion =

			<!--Identifiers-->
		⚫	\| CAS_number = 53716-44-2
		⚫	\| ATC_prefix = A03
		⚫	\| ATC_suffix = AA06
			\| PubChem = 68705
	\| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}}		\| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}}
	\| DrugBank =		\| DrugBank =
		⚫	\| UNII_Ref = {{fdacite\|correct\|FDA}}
	\| C=20\|H=37\|N=1\|O=3
		⚫	\| UNII = VI08KS44V0
⚫	\| molecular_weight = 339.51 g/mol

⚫	\| bioavailability =
			<!--Chemical data-->
⚫	\| protein_bound =
	\| ~~metabolism~~ =		\| C=20 \| H=37 \| N=1 \| O=3
		⚫	\| molecular_weight = 339.51 g/mol
⚫	\| elimination_half-life =
		⚫	\| synonyms = <small>(1''S'')-1-(diethylamino)propan-2-yl 1-hydroxybi(cyclohexane)-2-carboxylate</small>
⚫	\| excretion =
	\| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
⚫	\| pregnancy_US = <!-- A / B / C / D / X -->
⚫	\| pregnancy_category=
⚫	\| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
⚫	\| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫	\| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
⚫	\| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
⚫	\| legal_status =
⚫	\| routes_of_administration =
	}}		}}
	{{Unreferenced\|date=February 2009}}		{{Unreferenced\|date=February 2009}}

Revision as of 08:23, 3 September 2011

Pharmaceutical compound

Rociverine
Clinical data

Other names	(1S)-1-(diethylamino)propan-2-yl 1-hydroxybi(cyclohexane)-2-carboxylate
AHFS/Drugs.com	International Drug Names
ATC code	A03AA06 (WHO)
Identifiers
IUPAC name 2-(diethylamino)-1-methylethyl (1S)-1-hydroxy-1,1'-bi(cyclohexyl)-2-carboxylate
CAS Number	53716-44-2
PubChem CID	68705
UNII	VI08KS44V0
CompTox Dashboard (EPA)	DTXSID501023860
ECHA InfoCard	100.053.356
Chemical and physical data
Formula	C₂₀H₃₇NO₃
Molar mass	339.51 g/mol g·mol
(verify)

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Rociverine" – news · newspapers · books · scholar · JSTOR (February 2009) (Learn how and when to remove this message)

Rociverine is an antimuscarinic.

Drugs for functional gastrointestinal disorders (A03)

Drugs for
functional
bowel
disorders

Antimuscarinics

Tertiary amino group	Camylofin Dicycloverine Difemerine Dihexyverine Mebeverine Oxyphencyclimine Piperidolate Rociverine Trimebutine
Quaternary ammonium compounds	Benzilone Bevonium Diphemanil Fenpiverinium Glycopyrronium Hexocyclium Isopropamide Mepenzolate Methantheline Otilonium Oxyphenonium Penthienate Pipenzolate Poldine Prifinium Propantheline Tiemonium Timepidium Tridihexethyl

Phosphodiesterase
inhibitors

Acting on
serotonin receptors

Other

Belladonna
and derivatives
(antimuscarinics)

Tertiary amines: Atropine
Hyoscyamine

Propulsives

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

Categories: